TJB Medical, Inc.

BLAINE, MN · Founded 2020 · CIK 0001938367 · Medtech · Private

An articulated stylet/introducer device with micro-components for endotracheal intubation that improves airway access and reduces procedural injuries

access-airways.com →
Grants
$256K
1 award
Sector median: 1
Raised
$11K
1 Form D · Nov 2022
47 months since last filing
Contracts
—
No federal contracts on record
Patents
5
0 granted · 5 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · STTR Phase I: Minimally Invasive Articulating Intubation Stylet$256,000
Private capital raisedForm D · SEC$11,000
Federal grant · SBIR/STTRForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1261Innerspec Technologies Inc——
1262DeVoro Medical Inc.—$26M
1263Naveris, Inc.—$34M
1264TJB Medical, Inc.—$11K
1265QCMedchain LLC——
1266CytoTronics, Inc.—$14M
1267NanoSpy, Inc.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Christopher HaqqDirector · Executive Officer
  • Benn HorrisbergerDirector · Executive Officer
  • David MelanderDirector
  • Tom MoffatDirector
  • Jack RuegseggerDirector

Patents

USPTO · 0 granted of 5
  • Flexible Articulating Intubation Toolapplication
  • Flexible Articulating Intubation Toolapplication
  • Intubation Tool, System And Methodsapplication
  • Flexible Articulating Intubation Toolapplication
  • Flexible Articulating Intubation Tool With Cameraapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.